Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.45M | -1.20M | -952.20K | -725.10K | -497.90K |
| Total Depreciation and Amortization | 647.60K | 446.90K | 246.70K | 213.00K | 179.40K |
| Total Amortization of Deferred Charges | 292.10K | 292.10K | 292.10K | 146.10K | -- |
| Total Other Non-Cash Items | -1.25M | -1.79M | -2.33M | -1.55M | -774.10K |
| Change in Net Operating Assets | -92.90K | 913.10K | 1.92M | 791.40K | -335.40K |
| Cash from Operations | -1.85M | -1.34M | -825.90K | -1.13M | -1.43M |
| Capital Expenditure | -71.40K | -47.10K | -22.90K | -13.20K | -3.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 460.20K | 460.20K | 460.20K | 230.20K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 159.00K | 164.10K | 169.10K | 2.38M | 4.60M |
| Cash from Investing | 547.80K | 577.20K | 606.50K | 2.60M | 4.60M |
| Total Debt Issued | 6.76M | 4.49M | 2.22M | 2.61M | 3.00M |
| Total Debt Repaid | -1.06M | -1.10M | -1.14M | -3.08M | -5.01M |
| Issuance of Common Stock | 13.33M | 6.67M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -1.20M | -2.39M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -583.00K | -418.50K | -254.00K | 1.70M | 3.65M |
| Cash from Financing | 2.36M | 1.23M | 104.70K | 4.50K | -95.90K |
| Foreign Exchange rate Adjustments | -655.20K | -486.00K | -317.20K | -165.90K | -14.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.40K | -15.30K | -432.00K | 1.31M | 3.06M |